Axsos
Device Trauma & Extremeties
PDI 04546540685377
General payments
$7,386,479
Research payments
$315,463
Through program year 2025, $7,386,479 in general payments and $315,463 in research payments were reported against Axsos (Trauma & Extremeties).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
10 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $1,492,758 | 1,134 |
| 2025 | Research | $146,500 | 11 |
| 2024 | General | $1,740,656 | 2,526 |
| 2024 | Research | $78,520 | 7 |
| 2023 | General | $2,017,420 | 3,978 |
| 2023 | Research | $28,153 | 3 |
| 2022 | General | $1,297,854 | 1,997 |
| 2022 | Research | $24,100 | 1 |
| 2021 | General | $837,791 | 1,705 |
| 2021 | Research | $38,190 | 3 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 26 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 41 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
11,340 general · 25 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.